Dani Nazemian

Associate

I help our clients design and implement compensation arrangements for executives and employees.

dnazemian@cooley.com

Dani Nazemian focuses her practice in the areas of executive compensation and employee benefits for public and private companies. She advises clients in public offerings on issues related to equity arrangements and other forms of executive compensation. She designs and implements equity and incentive compensation plans, employee stock purchase plans, employment agreements, severance and change in control plans and other compensation arrangements. She also assists public companies with the disclosure of compensation arrangements in public filings and advises on the impact of ISS and Glass Lewis in connection with compensation and corporate governance matters.

Download full bio 

Experience

  • Jazz Pharmaceuticals Acquires Celator for $1.5 Billion 

  • AveXis – $95 Million IPO 

  • Dot Hill Systems sale to Seagate Technology 

  • ProNAi Therapeutics - $158 Million IPO 

  • ProNAi – $158 Million IPO 

  • View all

Practices & Industries

Passions

    Traveling

    Friends and family

    UCLA

     


Education

  • Boston College Law School
    JD, cum laude, 2013

  • Johns Hopkins University
    MHS, 2008

  • University of California, Los Angeles
    BS, Psychobiology
    cum laude, 2007


Admissions & Credentials

California